IP Library Granted Patent US 9,387,201
Granted Patent B2
US 9,387,201 · App. 14/167,285 · Granted Jul 12, 2016

Methods of providing anti-inflammation support

Inventor: Jonnie R. Williams (Bradenton, FL)
Assignee: RCP Development, Inc.
A61K31/444A23L1/0017A23L1/031A23L1/30A23L1/3002A23L1/303A61K31/07A61K31/4545A61K31/593A61K36/81A61K47/22A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,387,201
App. No.
14/167,285
Granted
Jul 12, 2016
Kind
B2
Abstract

This disclosure provides products, including pharmaceutical compositions and dietary supplements, which are useful for anti-inflammatory support.

Claims (4)

1. A method of providing anti-inflammation support, comprising administering to an individual in need thereof a lozenge comprising anatabine in an amount of about 1 mg, Vitamin A in an amount of about 417 IU, and Vitamin D3 in an amount of about 33 IU.

2. The method of claim 1 , wherein the product further comprises one or more additional ingredients selected from the group consisting of mannitol, natural mint flavors, artificial mint flavors, sucralose, silicon dioxide, stearic acid, hydroxypropyl methylcellulose, magnesium stearate, titanium dioxide, natural glaze, methyl parabens, propylparabens, triethyl citrate, citric acid, BHT, mono and diglycerides, and polysorbate 80.

3. A product in the form of a lozenge comprises anatabine in an amount of about 1 mg, retinyl acetate in an amount of about 417 IU, and chalecalciferol in an amount of about 33 IU.

4. The method of claim 3 , wherein the product further comprises one or more additional ingredients selected from the group consisting of mannitol, natural mint flavors, artificial mint flavors, sucralose, silicon dioxide, stearic acid, hydroxypropyl methylcellulose, magnesium stearate, titanium dioxide, natural glaze, methyl parabens, propylparabens, triethyl citrate, citric acid, BHT, mono and diglycerides, and polysorbate 80.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2018
From: ROCK CREEK PHARMACEUTICALS, INC.
To: PHILIP MORRIS PRODUCTS S.A.
Reel/Frame 046780/0050 →
CHANGE OF NAME Recorded Jul 14, 2014
From: ROCK CREEK PHARMACEUTICALS, INC.
To: RCP DEVELOPMENT, INC.
Reel/Frame 033309/0825 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2014
From: WILLIAMS, JONNIE R.
To: ROCK CREEK PHARMACEUTICALS, INC.
Reel/Frame 032080/0247 →
Continuity (3)
Division 13494237 · Jun 12, 2012
Provisional Application 61528380 · Aug 29, 2011
Related Publication 20140206656A1 · Jul 24, 2014